Search clinical trials for: glucose solution and Insulin

Total 23944 results

AstraZeneca

Completed

A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8 (ENERGIZE)

Hyperkalemia

United States, Russian Federation, Italy, Denmark
University of Aarhus
Aarhus University Hospital; University of Copenhagen; Lundbeck Foundation; Vejle... and other collaborators

Completed

Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders

Obesity | Diabetes Mellitus | Metabolic Syndrome | Hyperlipidemia | Arterial Hypertension

Denmark
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Withdrawn

Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin Secretion

Healthy

United States
Sanofi

Completed

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. (Lantus-P-CN)

Type 1 Diabetes Mellitus

China
Novo Nordisk A/S

Completed

Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

South Africa
Novo Nordisk A/S

Completed

Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Romania
Eli Lilly and Company

Completed

Assessment of Mealtime Bolus Insulin Behavior

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Completed

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Poland, Spain, Sweden, Malaysia, France, Netherlands, India, Argentina, South Africa, Romania, Former Serbia and Montenegro, Austria, Czech Republic, Philippines, Mexico
Assiut University

Not yet recruiting

Prevalence of IR in Overweight and Obese Adolescents (IR)

Insulin Resistance
Helse Stavanger HF

Completed

Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes

Diabetes Mellitus, Type 1

Norway
Jagdeesh Ullal
Wake Forest University Health Sciences

Active, not recruiting

Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes

Cystic Fibrosis-related Diabetes

United States
Novo Nordisk A/S

Completed

Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

Diabetes Mellitus, Type 2 | Diabetes

Hungary
Novo Nordisk A/S

Completed

Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes (IMPROVE Life)

Diabetes Mellitus, Type 2 | Diabetes

India
Sanofi

Completed

Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®

Type 1 Diabetes Mellitus

Germany
The Hospital for Sick Children

Completed

Determination of Lysine Requirement in the Parenterally Fed Neonate

Parenteral Lysine Requirements | Parenteral Feedings

Canada
Sanofi

Completed

Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy (Insuman-C25-CN)

Type 2 Diabetes Mellitus

China
University of Colorado, Denver

Completed

Insulin Pump to Multiple Daily Injection Transition Clinical Trial (TRANSITION)

Type 1 Diabetes

United States
Novo Nordisk A/S

Completed

Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Diabetes Mellitus, Type 2 | Diabetes

Slovenia
UPECLIN HC FM Botucatu Unesp
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Polidocanol Versus Glucose Treatment of Telangiectasia Trial (PG3T)

Varicose Veins | Telangiectasis

Brazil
Sanofi

Active, not recruiting

A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adult Type 2 Diabetic Participants on Basal Insulin in Taiwan (TW CES RCT)

Type 2 Diabetes Mellitus

Taiwan
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PRONTO-T2D)

Type 2 Diabetes Mellitus

United States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
University of Virginia
DexCom, Inc.; Tandem Diabetes Care, Inc.

Completed

Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp

Type 1 Diabetes Mellitus

United States
Wockhardt

Completed

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics

Diabetes

United States
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)

Diabetes Mellitus, Type 2 | Diabetes

Austria
Cairo University

Not yet recruiting

Insulin Iontophoresis Mixed With Oleic Acid Versus Topical Insulin in Patients With Chronic Diabetic Foot Ulcer

Diabetes Mellitus
Mannkind Corporation
Jaeb Center for Health Research

Active, not recruiting

INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

Diabetes Mellitus, Type 1

United States
Mannkind Corporation

Completed

Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Sanofi

Completed

A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes

Type 1 Diabetes

Germany
Hospices Civils de Lyon

Terminated

Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study. (CONTROLING)

Critical Illness

France
Sanofi

Completed

baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus (SUBSTITUTE)

Diabetes Mellitus, Type 1

Tunisia, South Africa, Algeria, Argentina, Brazil, Colombia, Kuwait, Mexico, Saudi Arabia
Benha University

Completed

Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients

COVID-19 | Dysglycemia

Egypt
Ministry of Health, Bahrain

Unknown

Effect of Insulin on Wound Healing-A Randomized Controlled Trial

Wound Heal
Mannkind Corporation

Completed

Afrezza With Basal Combination (ABC)

Type 1 Diabetes

United States
Transdermal Delivery Solutions Corp
Langford Research Institute, Inc.

Completed

Transdermal Insulin Response In Healthy Volunteers

Pharmacodynamic Response to Small Doses of Insulin

United States
Tampere University Hospital

Unknown

Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial

Gestational Diabetes | Hypoglycemia, Neonatal

Finland
University Hospital Tuebingen

Completed

Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans

Insulin Resistance

Germany
Sanofi

Completed

Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine (GEMELLI X)

Type 1 Diabetes Mellitus

United States
Hadassah Medical Organization

Withdrawn

Prolotherapy for the Treatment of Partial Rotator Cuff Tears

Rotator Cuff Tear

Israel
Novo Nordisk A/S

Completed

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment (Start)

Diabetes Mellitus, Type 2 | Diabetes

Finland
Universitat Politècnica de Valéncia
Hospital Clínico Universitario de Valencia

Recruiting

Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge (TAILOR/3)

Type 1 Diabetes

Spain
Sanofi

Completed

Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Japan
Novo Nordisk A/S

Completed

Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Argentina, Brazil
Clinical Nutrition Research Centre, Singapore

Completed

Liquid or Solid State of Food on Glycaemia, Lipaemia and Insulinaemia

Cardiovascular Disease | Diabetes

Singapore
UPECLIN HC FM Botucatu Unesp
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins

Varicose Veins

Brazil
Sanofi

Completed

A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Former Serbia and Montenegro
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes (EFFECTIVE)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Former Serbia and Montenegro
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Diabetes Mellitus, Type 2 | Diabetes

China
Royal Devon and Exeter NHS Foundation Trust
University of Oxford; Oxford University Hospitals NHS Trust; University of Exeter

Completed

Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes (DIVA-Exeter)

Diabetes Mellitus

United Kingdom
SepNet - Critical Care Trials Group
Novo Nordisk A/S; German Federal Ministry of Education and Research; B. Braun... and other collaborators

Completed

Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)

Septic Shock | Severe Sepsis

Germany

3

Subscribe